Grifols (GIFLF) Assets (2009 - 2025)
Grifols' (GIFLF) quarterly Assets came in at $22.9 billion in Q4 2025, little changed on a YoY basis from $22.9 billion in Q4 2024, and little changed quarter-over-quarter from $22.9 billion in Q4 2024.
Analysis
Grifols (GIFLF) Assets (2009 - 2025) Analysis & Trends
Grifols (GIFLF) has reported Assets for 17 consecutive years, with $22.9 billion the latest figure, recorded in Q4 2025.
- For the quarter ending Q4 2025, Assets changed 0.32% year-over-year to $22.9 billion; the trailing twelve-month figure through Dec 2025 stood at $22.9 billion (changed 0.32% YoY), and the FY2025 full-year result was $22.3 billion, up 21641.86% from the prior year.
- Assets was little changed at $22.9 billion in Q4 2025 per GIFLF's latest filing, from $22.9 billion in the prior quarter.
- Across five years, Assets topped out at $22.9 billion in Q4 2025 and bottomed at $8.4 billion in Q4 2021.
- Historically, Assets has averaged $19.7 billion across 5 years, with a median of $22.6 billion in 2023.
- The sharpest annual moves came in 2021 and 2022: Assets tumbled 54.04% in 2021, then jumped 158.76% in 2022.
- Over 5 years, Assets stood at $8.4 billion in 2021, then surged by 158.76% to $21.7 billion in 2022, then gained by 4.28% to $22.6 billion in 2023, then grew by 1.27% to $22.9 billion in 2024, then grew by 0.32% to $22.9 billion in 2025.
- According to Business Quant data, Assets over the past three periods registered $22.9 billion, $22.9 billion, and $22.6 billion for Q4 2025, Q4 2024, and Q4 2023 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 203.97 Bn | 189.99 Bn | 7.24 Bn | 95.64 Bn |
| 2 | Gilead Sciences | 178.74 Bn | 175.56 Bn | 6.22 Bn | 49.36 Bn |
| 3 | Vertex Pharmaceuticals | 130.73 Bn | 122.88 Bn | 2.84 Bn | 27.42 Bn |
| 4 | Regeneron Pharmaceuticals | 80.42 Bn | 72.42 Bn | 3.93 Bn | 41.73 Bn |
| 5 | Argenx Se | 60.40 Bn | 55.21 Bn | 1.37 Bn | 10.03 Bn |
| 6 | Moderna | 57.65 Bn | 52.52 Bn | 52.00 Mn | 10.96 Bn |
| 7 | Alnylam Pharmaceuticals | 33.37 Bn | 30.07 Bn | 992.69 Mn | 5.56 Bn |
| 8 | Biogen | 32.15 Bn | 30.86 Bn | 1.96 Bn | 32.09 Bn |
| 9 | Roivant Sciences | 29.58 Bn | 29.58 Bn | 1.16 Mn | 5.31 Bn |
| 10 | Grifols | 7.54 Bn | 9.09 Bn | 3.33 Bn | 22.95 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 22.95 Bn |
| Dec 31, 2024 | 22.87 Bn |
| Dec 31, 2023 | 22.59 Bn |
| Dec 31, 2022 | 21.66 Bn |
| Dec 31, 2021 | 8.37 Bn |
| Dec 31, 2020 | 18.21 Bn |
| Sep 30, 2020 | 18.28 Bn |
| Mar 31, 2020 | 17.55 Bn |
| Dec 31, 2019 | 17.20 Bn |
| Sep 30, 2019 | 15.62 Bn |
| Mar 31, 2019 | 15.22 Bn |
| Dec 31, 2018 | 14.24 Bn |
| Sep 30, 2018 | 13.70 Bn |
| Jun 30, 2018 | 13.65 Bn |
| Mar 31, 2018 | 16.45 Bn |
| Dec 31, 2017 | 12.86 Bn |
| Jun 30, 2017 | 12.22 Bn |
| Dec 31, 2016 | 10.94 Bn |
| Sep 30, 2016 | 10.68 Bn |
| Jun 30, 2016 | 10.78 Bn |